ATI Pharmacology Proctored Exam 2025|Verified 100%
i i i i i
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
ATI iPharmacology iProctor i new iupdated iexam iquestions iand ianswers idocs i2021
• A inurse iis iassessing ia iclient iwho iis ireceiving iintravenous itherapy. iThe inurse ishould iidentify
iwhich iof ithe ifollowing ifindings ias ia imanifestation iof ifluid ivolume iexcess?
• Decreased ibowel isounds
• Distended ineck iveins
• Bilateral imuscle iweakness
• Thread ipulse
• A inurse iis icaring ifor ia iclient iwho ihas ihyponatremia iand iis ireceiving ian iinfusion iof ia iprescribed
ihypertonic isolution. iWhich iof ithe ifollowing ifindings ishould iindicate ito ithe inurse ithat ithe
itreatment iis ieffective?
• Absent iChvostek’s isign
• Improved icognition
• Decreased ivomiting
• Cardiac iarrhythmias iabsent
• A inurse iis iteaching ia iclient iwho ihas ia inew iprescription ifor ia initroglycerin itransdermal ipatch.
iWhich iof ithe ifollowing iinstructions ishould ithe inurse iinclude?
• “Discontinue ithe ipatch iif iyou iexperience ia iheadache.”
• “Apply ia inew ipatch iif iyou ihave ichest ipain.”
• “Cover ithe ipatch iwith idry igauze iwhen itaking ia ishower.”
• “Remove ithe ipatch iprior ito igoing ito ibed.”
• A inurse iis ireviewing ihe ilaboratory iresults iof ia iclient iwho ihas ia iprescription ifor isodium
ipolystyrene isulfonate i(Kayexalate) ievery i6 ihr. iwhich iof ithe ifollowing ishould ithe inurse ireport ito
ithe iprovider?
• Creatinine i0.72 img/dL
• Sodium i138 imEq/L
• Magnesium i2 imEq/L
• Potassium i5.2 imEq/L i- iHyperkalemia i(serum ipotassium ilevel igreater ithan i5.0 imEq/L)
iincreases ithe iclient irisk ifor ifatal icardiac idysrhythmias. iKayexalate iis iused ito idecrease ithe
iserum ipotassium ilevel, iso ithe iPN ishould imonitor ithe iclient's iserum ipotassium ilevel
• A inurse iis icaring ifor ia iclient iwho ihas ituberculosis iand iis itaking iisoniazid iand irifampin. iWhich iof
ithe ifollowing ioutcomes iindicates ithat ithe iclient iis iadhering ito ithe imedication iregimen?
• The iclient ihas ia inegative isputum iculture
• The iclient itests inegative ifor iHIV
• The iclient ihas ia ipositive ipurified iprotein iderivative itest
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
• The iclient’s iliver ifunction itest iresults iare iwithin ithe iexpected ireference irange
• A iclient iis icaring ifor ia iclient iwho idevelops ian ianaphylactic ireaction ito iIV iadministration. iAfter
iassessing ithe iclient’s irespiratory istatus iand istopping ithe imedication iinfusion. iWhich iof ithe
ifollowing iactions ishould ithe inurse itake i next?
• Replace ithe iinfusion iwith i0.9% isodium ichloride
• Give idiphenhydramine iIM
• Elevate ithe iclient’s ilegs iand ifeet
• Administer iepinephrine iIM
• A inurse iis icaring ifor ia iclient iwho iis itaking isertraline iand ireports ia idesire ito ibegin itaking
isupplements. iWhich iof ithe ifollowing isupplements ishould ithe inurse iadvise ithe iclient ito iavoid?
• St. iJohn’s iWort
• Ginger iroot
• Black icohosh
• Coenzyme iQ10
• A inurse iis icaring ifor ia iclient iwho ihas iheart ifailure iand ia inew iprescription ifor ilisinopril. iFor iwhichiof
ithe ifollowing iadverse ieffects ishould ithe inurse imonitor iwhen iadministering ilisinopril?
• Bradycardia
• Hypokalemia
• Tinnitus
• Hypotension
• A inurse iis iassessing ia iclient iwho iis ireceiving iheparin iIV icontinuous iIV. iThe iclient ihas ian iPPT iof i90
iseconds. iThey ishould imonitor ithe iclient ifor iwhich iof ithe ifollowing ichanges iin itheir ivital isigns?
• Decreased itemperature
• Increased ipulse irate
• Decreased irespiratory irate
• Increased iblood ipressure
• A inurse iis ipreparing ito iadminister imedication ito ia iclient iand idiscovers ia imedication ierror. iThe
inurse ishould irecognize ithat iwhich iof ithe ifollowing istaff imembers iis iresponsible ifor icompleting
ian iincident ireport?
• The iquality iimprovement icommittee
• The inurse iwho iidentifies ithe ierror
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
i i i i i
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
ATI iPharmacology iProctor i new iupdated iexam iquestions iand ianswers idocs i2021
• A inurse iis iassessing ia iclient iwho iis ireceiving iintravenous itherapy. iThe inurse ishould iidentify
iwhich iof ithe ifollowing ifindings ias ia imanifestation iof ifluid ivolume iexcess?
• Decreased ibowel isounds
• Distended ineck iveins
• Bilateral imuscle iweakness
• Thread ipulse
• A inurse iis icaring ifor ia iclient iwho ihas ihyponatremia iand iis ireceiving ian iinfusion iof ia iprescribed
ihypertonic isolution. iWhich iof ithe ifollowing ifindings ishould iindicate ito ithe inurse ithat ithe
itreatment iis ieffective?
• Absent iChvostek’s isign
• Improved icognition
• Decreased ivomiting
• Cardiac iarrhythmias iabsent
• A inurse iis iteaching ia iclient iwho ihas ia inew iprescription ifor ia initroglycerin itransdermal ipatch.
iWhich iof ithe ifollowing iinstructions ishould ithe inurse iinclude?
• “Discontinue ithe ipatch iif iyou iexperience ia iheadache.”
• “Apply ia inew ipatch iif iyou ihave ichest ipain.”
• “Cover ithe ipatch iwith idry igauze iwhen itaking ia ishower.”
• “Remove ithe ipatch iprior ito igoing ito ibed.”
• A inurse iis ireviewing ihe ilaboratory iresults iof ia iclient iwho ihas ia iprescription ifor isodium
ipolystyrene isulfonate i(Kayexalate) ievery i6 ihr. iwhich iof ithe ifollowing ishould ithe inurse ireport ito
ithe iprovider?
• Creatinine i0.72 img/dL
• Sodium i138 imEq/L
• Magnesium i2 imEq/L
• Potassium i5.2 imEq/L i- iHyperkalemia i(serum ipotassium ilevel igreater ithan i5.0 imEq/L)
iincreases ithe iclient irisk ifor ifatal icardiac idysrhythmias. iKayexalate iis iused ito idecrease ithe
iserum ipotassium ilevel, iso ithe iPN ishould imonitor ithe iclient's iserum ipotassium ilevel
• A inurse iis icaring ifor ia iclient iwho ihas ituberculosis iand iis itaking iisoniazid iand irifampin. iWhich iof
ithe ifollowing ioutcomes iindicates ithat ithe iclient iis iadhering ito ithe imedication iregimen?
• The iclient ihas ia inegative isputum iculture
• The iclient itests inegative ifor iHIV
• The iclient ihas ia ipositive ipurified iprotein iderivative itest
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
, Stuvia.com - The Marketplace to Buy and Sell your Study Material
• The iclient’s iliver ifunction itest iresults iare iwithin ithe iexpected ireference irange
• A iclient iis icaring ifor ia iclient iwho idevelops ian ianaphylactic ireaction ito iIV iadministration. iAfter
iassessing ithe iclient’s irespiratory istatus iand istopping ithe imedication iinfusion. iWhich iof ithe
ifollowing iactions ishould ithe inurse itake i next?
• Replace ithe iinfusion iwith i0.9% isodium ichloride
• Give idiphenhydramine iIM
• Elevate ithe iclient’s ilegs iand ifeet
• Administer iepinephrine iIM
• A inurse iis icaring ifor ia iclient iwho iis itaking isertraline iand ireports ia idesire ito ibegin itaking
isupplements. iWhich iof ithe ifollowing isupplements ishould ithe inurse iadvise ithe iclient ito iavoid?
• St. iJohn’s iWort
• Ginger iroot
• Black icohosh
• Coenzyme iQ10
• A inurse iis icaring ifor ia iclient iwho ihas iheart ifailure iand ia inew iprescription ifor ilisinopril. iFor iwhichiof
ithe ifollowing iadverse ieffects ishould ithe inurse imonitor iwhen iadministering ilisinopril?
• Bradycardia
• Hypokalemia
• Tinnitus
• Hypotension
• A inurse iis iassessing ia iclient iwho iis ireceiving iheparin iIV icontinuous iIV. iThe iclient ihas ian iPPT iof i90
iseconds. iThey ishould imonitor ithe iclient ifor iwhich iof ithe ifollowing ichanges iin itheir ivital isigns?
• Decreased itemperature
• Increased ipulse irate
• Decreased irespiratory irate
• Increased iblood ipressure
• A inurse iis ipreparing ito iadminister imedication ito ia iclient iand idiscovers ia imedication ierror. iThe
inurse ishould irecognize ithat iwhich iof ithe ifollowing istaff imembers iis iresponsible ifor icompleting
ian iincident ireport?
• The iquality iimprovement icommittee
• The inurse iwho iidentifies ithe ierror
Downloaded by: lilianaleal17 |
Distribution of this document is illegal
